Celldex Therapeutics, Inc. Repayments of Subordinated Debt
Celldex Therapeutics, Inc. (CLDX) reported Repayments of Subordinated Debt of $12.50 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSubordinatedDebt · last filed 2012-03-08
- Celldex Therapeutics, Inc. repayments of subordinated debt for the quarter ending 2011-09-30 was $0.00.
- Celldex Therapeutics, Inc. repayments of subordinated debt for fiscal 2009 was $2.96M.
| Period end | Repayments of Subordinated Debt 3 month | Repayments of Subordinated Debt 6 month | Repayments of Subordinated Debt 9 month | Repayments of Subordinated Debt 12 month |
|---|---|---|---|---|
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $12.50M 10-Q · filed 2011-11-03 | ||
| 2011-06-30 | $12.50M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $2.96M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |